New dysphagia and medicines resource now live

May 1, 2013

Healthcare professionals caring for patients with dysphagia (swallowing difficulties) now have access to a new and comprehensive online resource called 'Medicines Optimisation in Patients with Dysphagia' (www.dysphagia-‐medicine.com/).

Researched and developed by the School of Pharmacy, Keele University, the website provides practical guidance on the administration of medicines to patients with dysphagia and summarises up to date evidence and research. It includes links to additional tools, publications, guidelines and ; all content is fully referenced.

Professor Stephen Chapman, Professor of Prescribing Studies at Keele University said, "As the population ages, patients with swallowing difficulties will present more frequently.This website aims to help and patients alike by
providing easy to access information on both the condition and the medicines available in a format that prescribers and their patients can use together or independently."

The site, which is supported by an unrestricted grant from Rosemont Pharmaceuticals, covers subjects in depth including Dysphagia, the Assessment & Management of Patients, Administration, Unlicensed Medicines, Specials, Tablet Splitting and Imported Products. A 'search' function: 'Find alternatives to solid dose medications', gives instant access to information about the available formats of medications, which will prove invaluable for pharmacists.

It has been estimated that 35-68% of older patients have some degree of swallowing dysfunction (1,2) which impacts on their quality of life and the administration of their medication (3,4). As the growing older population already accounts for one third of the UK's prescribing volume (5), is becoming an increasingly significant problem in terms of medicine administration and therapy.

Explore further: Dysphagia not tied to post-anterior cervical op swelling

Related Stories

Dysphagia not tied to post-anterior cervical op swelling

October 7, 2012
(HealthDay)—Although significant soft-tissue swelling can occur after anterior cervical discectomy and fusion (ACDF) procedures, the width of the prevertebral soft-tissue swelling on radiographic analysis does not correlate ...

Electrical brain stimulation can alleviate swallowing disorders after stroke

July 2, 2012
After stroke, patients often suffer from dysphagia, a swallowing disorder that results in greater healthcare costs and higher rates of complications such as dehydration, malnutrition, and pneumonia. In a new study published ...

Fluticasone improves histologic eosinophilia in esophagitis

June 29, 2012
(HealthDay) -- Swallowing aerosolized fluticasone improves histologic eosinophilia but does not improve dysphagia symptoms in adults with eosinophilic esophagitis (EoE), according to a study published online in the July issue ...

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.